U radu su izneseni rezultati ispitavanja dviju skupina ispitanika splitskog područja, i to: skupine od 191 bolesnika koji su bolovali od bubrežnog kamenca, a kamenci su bili analizirani infracrvenom spektrometrijom, i kontrolne skupine od 109 ispitanika, koji nisu bolovali od bubrežnog kamenca. Bolesnici su svrstani u pet skupina prema utvrđenom sastavu glavne komponente bubrežnog kamenca. Izvršeno je ispitivanje vrijednosti mokraćne kiseline u krvi i u 24 satnoj mokraći. Analizom krvi utvrđene su značajno veće vrijednosti mokraćne kiseline u krvi bolesnika, prosječno 361,64 H-mol/1, prema prosječnoj vrijednosti 325,04 jj.mol/1 nađene u ispitanika kontrolne skupine. Hiperurikurija je nađena u bolesnika koji su imali kamenac bubrega sastavljen od mokraćne kiseline i njene soli u 77,59% slučajeva i u bolesnika čiji su kamenci svrstani u skupinu mokraćna kiselina i drugi spojevi u 46,15% slučajeva, dok su ostali bolesnici, svrstani u ostale tri skupine, imali znatno niži postotak hiperurikurije. U ispitanika kontrolne skupine utvrđena je hiperurikurija u 46,37% slučajeva. Budući da i ispitanici kontrolne skupine imaju značajnu hiperurikuriju, a ne stvaraju bubrežni kamenac, ističe se značenje inhibitora kristalizacije kao činioca u sprečavanju agregacije kristala, odnosno onemogućavanju stvaranja bubrežnog kamenca. U radu se ističe značenje urikurije u stvaranju prvenstveno uratnih, a manje ostalih vrsta bubrežnih kamenaca., This review presents the results obtained by the examination of renal stone patients in the area of Split. There were 191 patients suffering from kidney stones and 109 in the control group, who had never suffered from the stone disease. The stones were analyzed by infrared spectrometry. The patients were ranged into 5 groups according to the main stone components. The level of uric acid in blood and in 24-hour-urine was also controlled. The blood analysis showed significantly higher average values of uric acid in stone formers (361.64 (imol/1), compared to the average values in the control group (325.04 umol/1). Hyperuricuria was found in 77.59% of patients with uric acid and urate stones and in 46.15% of patients with the stones composed of uric acid and other compounds. The patients in other three groups had much lower a percentage of hyperuricuria. In the control group hyperuricuria was found in 46.37% of cases. Since the members of the control group have a significant level of hyperuricuria, and yet do not form kidney stones, emphasis is put on the crystallization inhibitors as a factor in preventing the aggregation of crystals and the formation of stones. The authors emphasize hyperuricuria as an important factor in the urate stone formation, whereas its importance in the formation of other stone types is not so great.